The Ser503Ala mutation disrupts this cellular mechanism, impairing hepatic insulin clearance and thus leading to chronic hyperinsulinemia and ensuing insulin resistance, but without fasting hyperglycemia[15]. The gene discussed is INS; the disease is Insulin resistance.